Anxiety and depression in patients with advanced macular degeneration: current perspectives

Verena R Cimarolli,1 Robin J Casten,2 Barry W Rovner,3–5 Vera Heyl,6 Silvia Sörensen,7,8 Amy Horowitz9 1Research Institute on Aging, Jewish Home Lifecare, New York, NY, USA; 2Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College at Thomas Jefferson University...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cimarolli VR, Casten RJ, Rovner BW, Heyl V, Sörensen S, Horowitz A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/21ebdbc296f44f81b394cfa0f7a9e79d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:21ebdbc296f44f81b394cfa0f7a9e79d
record_format dspace
spelling oai:doaj.org-article:21ebdbc296f44f81b394cfa0f7a9e79d2021-12-02T03:20:21ZAnxiety and depression in patients with advanced macular degeneration: current perspectives1177-5483https://doaj.org/article/21ebdbc296f44f81b394cfa0f7a9e79d2015-12-01T00:00:00Zhttps://www.dovepress.com/anxiety-and-depression-in-patients-with-advanced-macular-degeneration--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Verena R Cimarolli,1 Robin J Casten,2 Barry W Rovner,3–5 Vera Heyl,6 Silvia Sörensen,7,8 Amy Horowitz9 1Research Institute on Aging, Jewish Home Lifecare, New York, NY, USA; 2Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 3Department of Neurology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 4Department of Psychiatry, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 5Department of Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 6Institute of Special Education, University of Education, Heidelberg, Germany; 7Warner School of Education and Human Development, University of Rochester, Rochester, NY, USA; 8Department of Ophthalmology, Flaum Eye Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; 9Graduate School of Social Service, Fordham University, New York, NY, USA Abstract: Age-related macular degeneration (AMD) – despite advances in prevention and medical treatment options – remains prevalent among older adults, often resulting in functional losses that negatively affect the mental health of older adults. In particular, the prevalence of both anxiety and depression in patients with AMD is high. Along with medical treatment options, low vision rehabilitation and AMD-specific behavioral and self-management programs have been developed and have demonstrated effectiveness in improving the mental health of AMD patients. This article reviews the prevalence of anxiety and depression in patients with advanced AMD, discusses potential mechanisms accounting for the development of depression and anxiety in AMD patients, presents the state-of the-art of available interventions for addressing anxiety and depression in AMD patients, and delineates recommendations for eye care professionals regarding how to screen for these two prevalent mental health problems and how to facilitate appropriate treatment for patients with AMD. Keywords: age-related macular degeneration, vision impairment, depression, anxiety, vision rehabilitation, behavioral and self-management interventionsCimarolli VRCasten RJRovner BWHeyl VSörensen SHorowitz ADove Medical PressarticleAge-related Macular DegenerationVision ImpairmentDepressionAnxietyVision RehabilitationBehavioral and Self-management InterventionsOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 55-63 (2015)
institution DOAJ
collection DOAJ
language EN
topic Age-related Macular Degeneration
Vision Impairment
Depression
Anxiety
Vision Rehabilitation
Behavioral and Self-management Interventions
Ophthalmology
RE1-994
spellingShingle Age-related Macular Degeneration
Vision Impairment
Depression
Anxiety
Vision Rehabilitation
Behavioral and Self-management Interventions
Ophthalmology
RE1-994
Cimarolli VR
Casten RJ
Rovner BW
Heyl V
Sörensen S
Horowitz A
Anxiety and depression in patients with advanced macular degeneration: current perspectives
description Verena R Cimarolli,1 Robin J Casten,2 Barry W Rovner,3–5 Vera Heyl,6 Silvia Sörensen,7,8 Amy Horowitz9 1Research Institute on Aging, Jewish Home Lifecare, New York, NY, USA; 2Department of Psychiatry and Human Behavior, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 3Department of Neurology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 4Department of Psychiatry, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 5Department of Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA; 6Institute of Special Education, University of Education, Heidelberg, Germany; 7Warner School of Education and Human Development, University of Rochester, Rochester, NY, USA; 8Department of Ophthalmology, Flaum Eye Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; 9Graduate School of Social Service, Fordham University, New York, NY, USA Abstract: Age-related macular degeneration (AMD) – despite advances in prevention and medical treatment options – remains prevalent among older adults, often resulting in functional losses that negatively affect the mental health of older adults. In particular, the prevalence of both anxiety and depression in patients with AMD is high. Along with medical treatment options, low vision rehabilitation and AMD-specific behavioral and self-management programs have been developed and have demonstrated effectiveness in improving the mental health of AMD patients. This article reviews the prevalence of anxiety and depression in patients with advanced AMD, discusses potential mechanisms accounting for the development of depression and anxiety in AMD patients, presents the state-of the-art of available interventions for addressing anxiety and depression in AMD patients, and delineates recommendations for eye care professionals regarding how to screen for these two prevalent mental health problems and how to facilitate appropriate treatment for patients with AMD. Keywords: age-related macular degeneration, vision impairment, depression, anxiety, vision rehabilitation, behavioral and self-management interventions
format article
author Cimarolli VR
Casten RJ
Rovner BW
Heyl V
Sörensen S
Horowitz A
author_facet Cimarolli VR
Casten RJ
Rovner BW
Heyl V
Sörensen S
Horowitz A
author_sort Cimarolli VR
title Anxiety and depression in patients with advanced macular degeneration: current perspectives
title_short Anxiety and depression in patients with advanced macular degeneration: current perspectives
title_full Anxiety and depression in patients with advanced macular degeneration: current perspectives
title_fullStr Anxiety and depression in patients with advanced macular degeneration: current perspectives
title_full_unstemmed Anxiety and depression in patients with advanced macular degeneration: current perspectives
title_sort anxiety and depression in patients with advanced macular degeneration: current perspectives
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/21ebdbc296f44f81b394cfa0f7a9e79d
work_keys_str_mv AT cimarollivr anxietyanddepressioninpatientswithadvancedmaculardegenerationcurrentperspectives
AT castenrj anxietyanddepressioninpatientswithadvancedmaculardegenerationcurrentperspectives
AT rovnerbw anxietyanddepressioninpatientswithadvancedmaculardegenerationcurrentperspectives
AT heylv anxietyanddepressioninpatientswithadvancedmaculardegenerationcurrentperspectives
AT sorensens anxietyanddepressioninpatientswithadvancedmaculardegenerationcurrentperspectives
AT horowitza anxietyanddepressioninpatientswithadvancedmaculardegenerationcurrentperspectives
_version_ 1718401781836283904